Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2089)
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
14,338
Price
$2.46
Total Value
$35.27K
Shares Held After
2,698,518
% of Holdings
0.5%
Contineum Therapeutics, Inc. (CTNM)
Stengone Carmine N. — Director
Shares
2,500
Price
$16.00
Total Value
$40.00K
Shares Held After
17,217
% of Holdings
12.7%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,400
Price
$0.96
Total Value
$5.21K
Shares Held After
361,985
% of Holdings
1.5%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
19,382
Price
$90.23
Total Value
$1.75M
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
100,195
Price
$90.23
Total Value
$9.04M
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
2,907
Price
$90.23
Total Value
$262.29K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
122,188
Price
$90.23
Total Value
$11.02M
Shares Held After
0
% of Holdings
100.0%
Disc Medicine, Inc. (IRON)
Yu Jonathan Yen-Wen — Chief Operating Officer
Shares
100
Price
$82.50
Total Value
$8.25K
Shares Held After
54,324
% of Holdings
0.2%
IONIS PHARMACEUTICALS INC (IONS)
BENNETT C FRANK — EVP, Chief Scientific Officer
Shares
15,000
Price
$85.46
Total Value
$1.28M
Shares Held After
0
% of Holdings
100.0%
IONIS PHARMACEUTICALS INC (IONS)
BENNETT C FRANK — EVP, Chief Scientific Officer
Shares
5,536
Price
$83.58
Total Value
$462.69K
Shares Held After
75,018
% of Holdings
6.9%
NEUROCRINE BIOSCIENCES INC (NBIX)
Delaet Ingrid — Chief Regulatory Officer
Shares
3,401
Price
$178.57
Total Value
$607.31K
Shares Held After
16,225
% of Holdings
17.3%
IONIS PHARMACEUTICALS INC (IONS)
Diaz Allene M. — Director
Shares
10,111
Price
$85.42
Total Value
$863.64K
Shares Held After
3,811
% of Holdings
72.6%
IONIS PHARMACEUTICALS INC (IONS)
Kordasiewicz Holly B. — EVP, Chief Development Officer
Shares
362
Price
$84.30
Total Value
$30.52K
Shares Held After
22,096
% of Holdings
1.6%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Borgeson Blake — Director
Shares
40,000
Price
$3.96
Total Value
$158.50K
Shares Held After
6,218,287
% of Holdings
0.6%
Immunome Inc. (IMNM)
Horn Kinney — CHIEF BUSINESS OFFICER
Shares
1,092
Price
$25.00
Total Value
$27.30K
Shares Held After
0
% of Holdings
100.0%
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
HRT FINANCIAL LP — 10% Owner
Shares
10,580
Price
$3.33
Total Value
$35.23K
Shares Held After
70,805
% of Holdings
13.0%
FORUM MARKETS Inc (FRMM)
Lomashuk Konstantin — 10% Owner
Shares
3,702
Price
$6.41
Total Value
$23.73K
Shares Held After
1,483,687
% of Holdings
0.2%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
85,918
Price
$44.86
Total Value
$3.85M
Shares Held After
2,469,959
% of Holdings
3.4%
Privia Health Group, Inc. (PRVA)
Mountcastle David — EVP & Chief Financial Officer
Shares
600
Price
$27.57
Total Value
$16.54K
Shares Held After
186,128
% of Holdings
0.3%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
2,200
Price
$43.59
Total Value
$95.91K
Shares Held After
151,994
% of Holdings
1.4%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
10,500
Price
$42.86
Total Value
$450.01K
Shares Held After
154,194
% of Holdings
6.4%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
32,550
Price
$42.07
Total Value
$1.37M
Shares Held After
164,694
% of Holdings
16.5%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
1,000
Price
$40.78
Total Value
$40.78K
Shares Held After
197,244
% of Holdings
0.5%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
85,918
Price
$44.86
Total Value
$3.85M
Shares Held After
2,469,959
% of Holdings
3.4%
IRONWOOD PHARMACEUTICALS INC (IRWD)
Silver Ronald — PFO & PAO
Shares
127,890
Price
$4.52
Total Value
$578.06K
Shares Held After
313,680
% of Holdings
29.0%
IDEAYA Biosciences, Inc. (IDYA)
Ruiz Briseno Andres — Chief Accounting Officer
Shares
9,550
Price
$40.01
Total Value
$382.13K
Shares Held After
26,466
% of Holdings
26.5%
Ceribell, Inc. (CBLL)
Chao Xingjuan — Director
Shares
23,554
Price
$19.90
Total Value
$468.72K
Shares Held After
802,317
% of Holdings
2.9%
Ceribell, Inc. (CBLL)
Chao Xingjuan — Director
Shares
1,446
Price
$19.90
Total Value
$28.78K
Shares Held After
802,317
% of Holdings
0.2%
Ceribell, Inc. (CBLL)
Chao Xingjuan — Director
Shares
14,000
Price
$19.90
Total Value
$278.60K
Shares Held After
802,317
% of Holdings
1.7%
Serina Therapeutics, Inc. (SER)
Brannan Stephen K. — Director
Shares
1,000
Price
$2.03
Total Value
$2.03K
Shares Held After
1,000
% of Holdings
100.0%
Pennant Group, Inc. (PNTG)
Guerisoli Brent — Chief Executive Officer
Shares
3,165
Price
$40.51
Total Value
$128.21K
Shares Held After
100,740
% of Holdings
3.0%
RESMED INC (RMD)
Farrell Michael J. — Director
Shares
4,991
Price
$218.55
Total Value
$1.09M
Shares Held After
466,223
% of Holdings
1.1%
Omada Health, Inc. (OMDA)
Cook Steven L. — Chief Financial Officer
Shares
12,337
Price
$23.09
Total Value
$284.84K
Shares Held After
187,209
% of Holdings
6.2%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
15,810
Price
$2.48
Total Value
$39.21K
Shares Held After
2,684,180
% of Holdings
0.6%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
952
Price
$93.54
Total Value
$89.05K
Shares Held After
3,985
% of Holdings
19.3%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
19,048
Price
$93.11
Total Value
$1.77M
Shares Held After
4,937
% of Holdings
79.4%
PALISADE BIO, INC. (PALI)
Finley John David — Director
Shares
146,798
Price
$2.07
Total Value
$303.34K
Shares Held After
217,555
% of Holdings
40.3%
PALISADE BIO, INC. (PALI)
Jones Mitchell Lawrence — Chief Medical Officer
Shares
51,880
Price
$2.05
Total Value
$106.54K
Shares Held After
94,009
% of Holdings
35.6%
PALISADE BIO, INC. (PALI)
Baltera Robert Jr. — Director
Shares
30,000
Price
$2.03
Total Value
$61.04K
Shares Held After
416,904
% of Holdings
7.2%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
107,429
Price
$0.31
Total Value
$33.30K
Shares Held After
0
% of Holdings
100.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
5,000
Price
$23.61
Total Value
$118.05K
Shares Held After
2,962
% of Holdings
62.8%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
11,665
Price
$23.62
Total Value
$275.53K
Shares Held After
815,054
% of Holdings
1.4%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
49,193
Price
$23.17
Total Value
$1.14M
Shares Held After
826,719
% of Holdings
5.6%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
14,844
Price
$23.62
Total Value
$350.62K
Shares Held After
1,140,150
% of Holdings
1.3%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
62,543
Price
$23.17
Total Value
$1.45M
Shares Held After
1,154,994
% of Holdings
5.1%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
29,587
Price
$23.62
Total Value
$698.84K
Shares Held After
4,069,482
% of Holdings
0.7%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
124,379
Price
$23.17
Total Value
$2.88M
Shares Held After
4,099,069
% of Holdings
2.9%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
9,288
Price
$89.44
Total Value
$830.72K
Shares Held After
60,299
% of Holdings
13.3%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
11,369
Price
$89.03
Total Value
$1.01M
Shares Held After
69,587
% of Holdings
14.0%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
3,956
Price
$87.17
Total Value
$344.84K
Shares Held After
80,956
% of Holdings
4.7%
Showing 51–100 of 2089 transactions (page 2 of 42)